Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Top Cited Papers
- 1 April 2002
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 159 (4) , 561-566
- https://doi.org/10.1176/appi.ajp.159.4.561
Abstract
OBJECTIVE: The development of both type I and type II diabetes after initiation of some atypical neuroleptics has been reported, primarily in studies involving small series of patients. This study ...Keywords
This publication has 29 references indexed in Scilit:
- From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans AffairsMedical Care, 2001
- Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisBMJ, 2000
- Prevalence and Correlates of Diabetes in National Schizophrenia SamplesSchizophrenia Bulletin, 2000
- Novel antipsychotics and new onset diabetesBiological Psychiatry, 1998
- Access to Public Mental Health ServicesMedical Care, 1998
- Quetiapine in Patients With SchizophreniaArchives of General Psychiatry, 1997
- Ketoacidosis as a side‐effect of clozapine: a case reportActa Psychiatrica Scandinavica, 1996
- Diabetes mellitus in schizophrenic patientsComprehensive Psychiatry, 1996
- Weight gain associated with clozapineAmerican Journal of Psychiatry, 1990
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988